Mindset Pharma Inc. has patented new indoline derivatives acting as 5-HT1A receptor agonists and thus reported to be useful for the treatment of neurological and psychiatric disorders.
U-93385E is a high intrinsic activity 5-HT1A agonist with potent antianxiety effects in animal models. In the course of evaluating this compound, we sought to determine whether it shared with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback